Biora Therapeutics, Inc. Common Stock
BIOR
BIOR was delisted on the 10th of December, 2024.
20 hedge funds and large institutions have $6.13M invested in Biora Therapeutics, Inc. Common Stock in 2024 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 5 reducing their positions, and 9 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
20% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 5
23% less funds holding
Funds holding: 26 → 20 (-6)
24% less capital invested
Capital invested by funds: $8.07M → $6.13M (-$1.94M)
67% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 9
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$54.4K |
| 2 |
HF
HRT Financial
New York
|
+$21.9K |
| 3 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$2.78K |
| 4 |
AW
Avion Wealth
The Woodlands,
Texas
|
+$974 |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$915 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TSS
Two Sigma Securities
New York
|
-$32.1K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
-$20.6K |
| 3 |
LRIA
Leonard Rickey Investment Advisors
Yakima,
Washington
|
-$9.63K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$8.93K |
| 5 |
SSA
Schonfeld Strategic Advisors
New York
|
-$7.99K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
RhumbLine Advisers
Boston,
Massachusetts
| – | -$10 | -2 | Closed |
|
|
CA
27
CoreCap Advisors
Southfield,
Michigan
| – | -$8 | -1 | Closed |
|
|
CPG
28
Cornerstone Planning Group
Fairfield,
New Jersey
| – | -$4 | -1 | Closed |
|
|
HI
29
Harbour Investments
Madison,
Wisconsin
| – | -$3 | – | – |
|
30
UBS Group
Zurich,
Switzerland
| – | -$1 | – | – |
|
|
AW
31
Avion Wealth
The Woodlands,
Texas
| – | +$974 | +150 | New |
|
BIOR Hedge Fund Activity: Q3 2024 in Review
20 of the 6,965 institutional investors tracked by Wall St. Rank reported a position in Biora Therapeutics, Inc. Common Stock (BIOR) for Q3 2024, worth a combined $6.13M — down 24% from $8.07M a quarter earlier.
Sellers outnumbered buyers: 9 funds closed out of BIOR and 3 opened new positions — a net loss of 6 holders — while 5 trimmed existing stakes and 4 added.
The largest buyer was Morgan Stanley, adding an estimated $54.4K. The largest seller was Two Sigma Securities, cutting an estimated $32.1K.
- 20 institutional investors held Biora Therapeutics, Inc. Common Stock (BIOR) as of Q3 2024, down from 26 in Q2 2024.
- Funds reported $6.13M of Biora Therapeutics, Inc. Common Stock stock for Q3 2024, down 24% quarter-over-quarter.
- 3 funds opened new Biora Therapeutics, Inc. Common Stock positions in Q3 2024 and 9 closed out, a net change of -6 holders.
- The largest Biora Therapeutics, Inc. Common Stock buyer in Q3 2024 was Morgan Stanley, an estimated $54.4K added.
- The largest Biora Therapeutics, Inc. Common Stock seller in Q3 2024 was Two Sigma Securities, an estimated $32.1K sold.
Based on aggregated 13F filings for Q3 2024.